Skip to the page

Data / Form D filings / CytoAgents, Inc.

CytoAgents, Inc.: Form D filings

CytoAgents, Inc., a health care company in Pittsburgh, PA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on May 16, 2023, reports $7 million sold of a $15.2 million offering to 23 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
100 S COMMONS #102, Pittsburgh, PA, 15212
Phone
(412) 303-1200
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1877258

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 16, 2023New notice$15,204,008$7,003,238$8,200,77023May 3, 2023sec.gov
Aug 12, 2021New notice$6,500,000$6,106,500$393,50023Jul 30, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roy L PriebExecutive Officer
Robert L FerrisDirector
Stanley MarksDirector
Teresa WhalenExecutive Officer, Director
Anthony McCarleyDirector
Catherine MottDirector

Other health care companies in Pennsylvania that filed recently

Every Form D from the week of May 15, 2023 · All recent filings in Pennsylvania · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what CytoAgents, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.